Zobrazeno 1 - 10
of 40
pro vyhledávání: '"NNT, Number needed to treat"'
Publikováno v:
Medical Care, 2001 Oct 01. 39(10), 1039-1047.
Externí odkaz:
https://www.jstor.org/stable/3767561
Autor:
Angela Bellani, Martina Garuti, Linda Vignozzi, Giulia Rastrelli, Michele Nicchio, Claudia Glingani, Gianpaolo Castelli, Gloria Beduzzi, Carlo Mengoli, Mario Morandi, Sara Cerzosimo, Massimo Franchini, Salvatore Casari, Massimo Amato, Massimiliano Beccaria, Roberto Antonio Petilino, Giovanni Corghi, Vincenza Di Stasi, Francesco Inglese, Andrea Storti, Beatrice Caruso, Giuseppe De Donno, M. Pagani
Publikováno v:
Mayo Clinic Proceedings: Innovations, Quality & Outcomes, Vol 5, Iss 2, Pp 403-412 (2021)
Mayo Clinic Proceedings: Innovations, Quality & Outcomes
Mayo Clinic Proceedings: Innovations, Quality & Outcomes
Objective To assess the safety and efficacy of convalescent plasma (CP) transfusion in elderly people with moderate to severe coronavirus disease 2019 (COVID-19) living in a long-term care facility (LTCF). Patients and Methods Twenty-two consecutive
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::9004b859476fc873ca170a5fe0b884d9
https://doi.org/10.1016/j.mayocpiqo.2021.01.010
https://doi.org/10.1016/j.mayocpiqo.2021.01.010
Autor:
Aayush K. Singal, Ganesan Karthikeyan
Publikováno v:
Indian Heart Journal
Indian Heart Journal, Vol 71, Iss 2, Pp 113-117 (2019)
Indian Heart Journal, Vol 71, Iss 2, Pp 113-117 (2019)
Aspirin is one of the oldest and most commonly used cardiovascular drugs. Despite there being high-quality evidence supporting the use of aspirin for patients with known cardiovascular disease, a definitive consensus regarding its use for patients at
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::b12ed39f7c4d9d1322818bd95b063caa
http://europepmc.org/articles/PMC6620426
http://europepmc.org/articles/PMC6620426
Autor:
Akio Niimi, Woo-Jung Song
Publikováno v:
The Journal of Allergy and Clinical Immunology. in Practice
Background Angiotensin converting enzyme inhibitor (ACEI) intolerance commonly occurs, requiring switching to an angiotensin-II receptor blocker (ARB). Angiotensin converting enzyme inhibitor intolerance may be mediated by bradykinin, potentially aff
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::22bb25a877d5efaa654b8965ed0e2944
https://pubmed.ncbi.nlm.nih.gov/33965593
https://pubmed.ncbi.nlm.nih.gov/33965593
Autor:
Pardeep S. Jhund, Stuart J. Pocock, Brian Claggett, Kieran F. Docherty, Faiez Zannad, John J.V. McMurray, Scott D. Solomon, John Gregson, João Pedro Ferreira, Susan Stienen, Mark C. Petrie
Publikováno v:
JACC. Heart failure, 8(12), 984-995. Elsevier BV
Jacc. Heart Failure
JACC: Heart Failure
JACC: Heart Failure, Elsevier/American College of Cardiology, 2020, 8 (12), pp.984-995. ⟨10.1016/j.jchf.2020.08.004⟩
Jacc. Heart Failure
JACC: Heart Failure
JACC: Heart Failure, Elsevier/American College of Cardiology, 2020, 8 (12), pp.984-995. ⟨10.1016/j.jchf.2020.08.004⟩
Objectives This study compared ways of describing treatment effects. The objective was to better explain to clinicians and patients what they might expect from a given treatment, not only in terms of relative and absolute risk reduction, but also in
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::6f6bc1c9df07012d173433c09fadc040
https://pure.amc.nl/en/publications/estimating-the-lifetime-benefits-of-treatments-for-heart-failure(8d86b181-8060-4405-a0a4-0766513dfce7).html
https://pure.amc.nl/en/publications/estimating-the-lifetime-benefits-of-treatments-for-heart-failure(8d86b181-8060-4405-a0a4-0766513dfce7).html
Publikováno v:
JACC: CardioOncology
Venous thromboembolism (VTE), including deep vein thrombosis and pulmonary embolism, represents a major cause of morbidity and mortality in patients with cancer. Arterial thromboembolism, including myocardial infarction and stroke, is also prevalent.
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::5b57f3ebe08b759ba5d57d38cac1341b
https://pubmed.ncbi.nlm.nih.gov/34396323
https://pubmed.ncbi.nlm.nih.gov/34396323
Autor:
Amanda Levine, Orit Markowitz
Publikováno v:
JAAD Case Reports, Vol 4, Iss 10, Pp 1014-1023 (2018)
JAAD Case Reports
JAAD Case Reports
Reflectance confocal microscopy (RCM) is a novel technology that provides noninvasive, in vivo imaging of the skin at nearly histologic resolution. In 2016, the US Centers for Medicare and Medicaid Services (CMS) established reimbursement codes for R
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::5475de56d2f4a51e9aa8f6d608c75614
https://doi.org/10.1016/j.jdcr.2018.09.019
https://doi.org/10.1016/j.jdcr.2018.09.019
Publikováno v:
The Journal of Allergy and Clinical Immunology. in Practice
Given the prevalence and impact of childhood food allergy, there is increasing interest in interventions targeting disease prevention. Although interventions such as early introduction of dietary peanut have demonstrated efficacy in a small number of
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=pmid_dedup__::873c4d837a4de06e479902f3ed2c4a4b
http://europepmc.org/articles/PMC5840515
http://europepmc.org/articles/PMC5840515
Publikováno v:
JHEP Reports
Summary In this review, we summarise the current knowledge on the indications and contraindications of transjugular intrahepatic portosystemic shunt (TIPS) placement for the treatment of the complications of portal hypertension in cirrhosis, specific
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::6a3eaaafc10d7b86f63f64113ac16a71
https://pubmed.ncbi.nlm.nih.gov/32671331
https://pubmed.ncbi.nlm.nih.gov/32671331
Publikováno v:
JHEP Reports
G. Rodrigues, Susana; Mendoza, Yuly P.; Bosch, Jaime (2020). Beta-blockers in cirrhosis: Evidence-based indications and limitations. JHEP reports, 2(1), p. 100063. Elsevier 10.1016/j.jhepr.2019.12.001
G. Rodrigues, Susana; Mendoza, Yuly P.; Bosch, Jaime (2020). Beta-blockers in cirrhosis: Evidence-based indications and limitations. JHEP reports, 2(1), p. 100063. Elsevier 10.1016/j.jhepr.2019.12.001
Summary Non-selective beta-blockers (NSBBs) are the mainstay of treatment for portal hypertension in the setting of liver cirrhosis. Randomised controlled trials demonstrated their efficacy in preventing initial variceal bleeding and subsequent reble
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::a816a74e0b7dfe5f8bdba17c687e9104
http://europepmc.org/articles/PMC7005550
http://europepmc.org/articles/PMC7005550